Lipid compositions with the ability to self-assemble into biocompatible nano-and mesostructured functional materials have many potential uses in modern medicine. By using twocomponent lipid systems, it is possible to tune the structure formation and related functional properties, e.g., the encapsulation and extended release of small molecules and peptides, by simply varying the ratio of the lipid building blocks. This is shown in detail for the binary phosphatidylcholine and diglyceride lipid systems, which are currently being used in multiple programs for the development of novel pharmaceuticals and marketed products.The ability of certain lipids to self-assemble into functional reversed-phase nonlamellar liquid crystal (LC) gels in contact with aqueous media, make such systems highly interesting for use as ambient responsive delivery systems using such functional features as bioadhesion, biodegradation, encapsulation, and controlled release.1 By exploiting the liquid-to-LC gel transition triggered on exposure of lipid solutions to aqueous media, it is possible to combine excellent in vivo encapsulation and extended release properties of some reversed LC gel phases, with the easy manufacturing and administration properties of relatively low-viscosity nonaqueous lipid solutions comprising small amounts of nonaqueous solvent.
1,2The most frequently used nonlamellar LC-forming lipid in drug delivery-related studies has been glycerol monooleate (GMO).3,4 At physiological conditions in excess water, GMO forms a bilayer-based bicontinuous cubic phase (V 2 ) with the Pn3m space group representing a three-dimensional network of hydrophilic and hydrophobic domains. Although a promising candidate for several applications, GMO-based LCs have been shown to exhibit a pronounced tendency to disrupt membrane structures, e.g., extensive hemolytic activity.5 Furthermore, the one-component GMO system has further limitations with respect to the drug delivery application in the difficulty of compensating for any phase changes caused by solubilizing drug compounds. 6 The use of a two or multicomponent system can typically alleviate this issue and can allow for compensation of unwanted phase changes by simply adjusting the ratio of the lipid building blocks. One example of such a system is the two-component unsaturated (e.g., dioleoyl) phosphatidylcholine (PC) and glycerol dioleate (GDO) system, where PC has a preference for the planar lamellar LC phase (L ¡ ) and GDO for the reversed liquid micellar phase (L 2 ). Between these extremes at full hydration reversed 2D hexagonal (H 2 ), reversed micellar cubic (I 2 ) with the Fd3m space group as well as two-and three-phase regions are formed.
711A recent study on the in vitro release of disodium fluorescein from soy PC (SPC)/GDO nonlamellar LCs has shown that the minimum of release (lowest release rates) can be found for compositions in the two-phase region between the H 2 and I 2 phases.1 Importantly, the observed release of both for small molecules 1 and peptides 2 from these phases ...